Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia

Lasers in Surgery and Medicine

Volumn 46, Issue 6, 2014, Pages 456-461

  Hillemanns, Peter ^a   Petry, Karl Ulrich ^b   Soergel, Philipp ^a   Collinet, Pierre ^c   Ardaens, Katty ^c   Gallwas, Julia ^d   Luyten, Alexander ^b   Dannecker, Christian ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Clinic for Gynecology Obstetrics and Gynecological Oncology   (Germany)

^c UNIV LILLE   (France)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

cervical cancer; CIN; hexaminolevulinate; HPV; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; PLACEBO; AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; SUPPOSITORY;

ABDOMINAL CRAMP; ADULT; ARTICLE; CANCER PATIENT; CATHETER; COLPOSCOPY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ILLUMINATION; LASER; LEUKORRHEA; LIGHT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TUMOR REGRESSION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERUS BIOPSY; WART VIRUS; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIAL; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; SUPPOSITORY; TREATMENT OUTCOME; VAGINA;

ADULT; AMINOLEVULINIC ACID; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SUPPOSITORIES; TREATMENT OUTCOME; VAGINA;

EID: 84904499292     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22255     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics. CA Cancer J Clin 2002; 55 (2): 74-108.
2. zur Hausen H,. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2 (5): 342-350. (Pubitemid 37328947)
3. Ferenczy A, Franco E,. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3 (1): 11-16. (Pubitemid 34121141)
4. Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E,. Progression and regression of incident cervical HPV6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2007; 2: 15.
5. Insinga RP, Dasbach EJ, Elbasha EH,. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: A critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009; 9: 119.
6. Duggan MA, McGregor SE, Stuart GC, Morris S, Chang-Poon V, Schepansky A, Honore L,. The natural history of CIN I lesions. Eur J Gynaecol Oncol 1998; 19 (4): 338-344. (Pubitemid 28379199)
7. Martin-Hirsch PL, Whitehurst C, Buckley CH, Moore JV, Kitchener HC,. Photodynamic treatment for lower genital tract intraepithelial neoplasia. Lancet 1998; 351 (9113): 1403. (Pubitemid 28210001)
8. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E,. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis. Lancet 2006; 367 (9509): 489-4898.
9. Ortoft G, Henriksen T, Hansen E, Petersen L,. After conisation of the cervix, the perinatal mortality as a result of preterm delivery increases in subsequent pregnancy. BJOG 2010; 117 (3): 258-267.
10. Soergel P, Dahl GF, Onsrud M, Hillemanns P,. Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate-A double-blind, dose-finding study. Lasers Surg Med 2012; 44 (6): 468-474.
11. Castano AP, Mroz P, Hamblin MR,. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006; 6 (7): 535-545. (Pubitemid 43980542)
12. Soergel P, Loehr-Schulz R, Hillemanns M, Landwehr S, Makowski L, Hillemanns P,. Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium. Lasers Surg Med 2010; 42 (9): 624-630.
13. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ,. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76 (Pt 4): 1057-1062.
14. Soergel P, Wang X, Stepp H, Hertel H, Hillemanns P,. Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate. Lasers Surg Med 2008; 40 (9): 611-615.
15. Brun JL, Dalstein V, Leveque J, Mathevet P, Raulic P, Baldauf JJ, Scholl S, Huynh B, Douvier S, Riethmuller D, Clavel C, Birembaut P, Calenda V, Baudin M, Bory JP,. Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy. Am J Obstet Gynecol 2011; 204 (2): 169.e1-169.e8.
16. Ruffin MT, Bailey JM, Normolle DP, Michael CW, Bieniasz ME, Kmak DC, Unger ER, Brenner DE,. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III. Cancer Epidemiol Biomarkers Prev 2004; 13 (12): 2148-2152. (Pubitemid 40054310)
17. Grimm C, Polterauer S, Natter C, Rahhal J, Hefler L, Tempfer CB, Heinze G, Stary G, Reinthaller A, Speiser P,. Treatment of cervical intraepithelial neoplasia with topical imiquimod. Obstet Gynecol 2012; 120 (1): 152-159.
18. Bodner K, Bodner-Adler B, Wierrani F, Kubin A, Szölts-Szölts J, Spängler B, Grünberger W,. Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: A comparison of preliminary results. Anticancer Res 2003; 23 (2C): 1785-1788. (Pubitemid 36750849)
19. Wierrani F, Kubin A, Jindra R, Henry M, Gharehbaghi K, Grin W, Söltz-Szötz J, Alth G, Grünberger W,. 5-aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix-A new experimental approach. Cancer Detect Prev 1999; 23 (4): 351-355. (Pubitemid 29311597)
20. Daayana S, Winters U, Stern PL, Kitchner HC,. Clinical and immunological response to photodynamic therapy in the treatment of vulva intraepithelial neoplasia. Photochem Photobiol 2011; 10: 802-809.
21. Kabingu E, Oseroff AR, Wilding GE, Gollnick SO,. Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res 2009; 15 (13): 4460-4466.
22. Einstein M, Sørdal T, Lund T,. Safety of Hexaminolevulinate photodynamic therapy-A non-extirpative treatment for cervical neoplasia (CIN), abstract ASSCP. San Francisco, CA.